GET DAILY SIGNALSWhy Is Acadia Healthcare (ACHC) Stock Up +7.75% Today?
Key Takeaways
- ACHC shares climbed +7.75% to $34.75, up $2.50 from the prior session's close of $32.25.
- The primary catalyst was a third-quarter earnings beat and a third consecutive quarter of raised full-year guidance.
- Adjusted EPS of $0.60 topped the $0.46 consensus, while revenue of $895.3 million exceeded estimates of $877.76 million.
- The stock is extending a powerful multi-session rally and has more than doubled year-to-date, well ahead of the broader market.
- Traders are watching volume, the stock's approach to its 52-week high, and follow-through from management's conference call commentary.
- Explore Price Targets, Earnings, and Forecast pages for deeper analysis of this ticker.
- Discover how AI-driven strategies are navigating this move on the Trending AI Robots page.
Opening Summary
Acadia Healthcare Company, Inc. (ACHC), the largest stand-alone behavioral healthcare provider in the United States, saw its shares surge in today's session as investors continued to reward a strong third-quarter earnings report and an upward revision to full-year guidance. The stock climbed +7.75% to $34.75, up from a prior close of $32.25. Acadia operates roughly 280 behavioral health facilities across 40 states and Puerto Rico, serving more than 85,000 patients daily, with additional operations in the United Kingdom under the Priory brand. The market's immediate focus was on better-than-expected quarterly results and management's confident outlook.
Earnings Beat and Raised Guidance
The dominant driver behind the price rally was Acadia's third-quarter 2026 financial performance. The company reported revenue of $895.3 million, an increase of 5.1% year over year and above the consensus estimate of approximately $877.8 million. Adjusted earnings per share came in at $0.60, well ahead of the $0.46 analysts had projected, while adjusted EBITDA rose to $176.4 million from $173.0 million in the prior-year period. Same-facility revenue grew 5.2%, supported by higher patient days and an increase in revenue per patient day.
Equally important, management raised its full-year 2026 outlook for the third consecutive quarter. The company now expects revenue of $3.44 billion to $3.46 billion, adjusted EBITDA of $615 million to $625 million, and adjusted EPS of $1.70 to $1.80 — a midpoint meaningfully above the prior consensus of roughly $1.55. This combination of a top- and bottom-line beat with stronger forward guidance reinforced investor confidence in the company's expansion strategy and operational execution.
Capacity Expansion and Operational Momentum
Underpinning the positive reaction was evidence of continued growth in Acadia's footprint. During the quarter, the company added 220 licensed beds, including the opening of a 144-bed de novo facility near Jacksonville, Florida, and brought its total 2026 bed additions to 542. Management also signaled confidence in future contributions from new acute facilities, pointing to meaningful incremental EBITDA expected in 2027. This capacity expansion, coupled with improving admissions trends in its comprehensive treatment center (CTC) service line, gave investors a tangible growth narrative beyond the headline numbers.
Market Context and Trading Activity
The earnings-driven move unfolded on elevated trading volume. On the prior session, more than three million shares changed hands, roughly double Acadia's typical average daily volume, reflecting broad participation in the rally. The stock has now cleared several technical levels and is trading near the upper end of its 52-week range, with its fifty-day and two-hundred-day moving averages sitting well below current levels. The strength has been company-specific rather than purely a function of broad market or sector momentum, as Acadia's year-to-date gain of more than 100% has far outpaced the S&P 500's advance.
What Comes Next for ACHC
Looking ahead, investors will be watching whether Acadia can sustain its same-facility revenue growth and convert its expanding bed capacity into higher profitability. Key areas of focus include the progress of supplemental payment programs in Florida and Ohio, which management estimates could add more than $20 million in incremental EBITDA if approved, as well as the company's continued revenue-cycle initiatives. Risks include potential Medicaid reimbursement pressures, higher labor and operating costs, and the execution challenges inherent in ramping up newly opened facilities. Management's November conference appearances may provide additional color on the fourth quarter and beyond.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of the platform's strongest-performing AI trading bots under current market conditions. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Investors tracking moves like today's rally in ACHC may find value in exploring these automated approaches to identify emerging opportunities.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ACHC's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Indicator for ACHC moved out of overbought territory on October 15, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In 22 of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at 81%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ACHC turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
ACHC broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 63 cases where ACHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ACHC as a result. In 69 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
ACHC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ACHC crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +4.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHC advanced for three days, in 192 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 120 of 187 cases where ACHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ACHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.517) is normal, around the industry mean (204.059). P/E Ratio (-2.599) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (0.380) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (0.758) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an operator of a network of behavioral health centers
Industry HospitalNursingManagement
Advertisement